F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,633 | 4,901 | 34,371 | 10,547 | 16,750 |
| Marketable Securities | 16,873 | N/A | 28,778 | 38,646 | 29,857 |
| Receivables | N/A | 10,532 | N/A | N/A | N/A |
| TOTAL | $50,467 | $19,021 | $64,876 | $51,595 | $47,825 |
| Non-Current Assets | |||||
| PPE Net | 2,140 | 1,425 | 2,264 | 2,353 | 2,307 |
| Investments And Advances | 0 | 0 | 0 | 0 | 10,873 |
| Intangibles | 0 | 4,320 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,917 | 13,712 | 3,053 | 3,119 | 3,347 |
| TOTAL | $5,057 | $19,457 | $5,317 | $5,472 | $16,527 |
| Total Assets | $55,524 | $38,478 | $70,193 | $57,067 | $64,352 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,147 | 14,906 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,992 | 5,056 | 2,986 | 1,725 | 1,986 |
| Accrued Expenses | 2,486 | 8,876 | 1,998 | 3,185 | 1,693 |
| TOTAL | $24,391 | $29,890 | $5,327 | $5,242 | $3,948 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 19,011 | N/A | N/A |
| Deferred Revenues | N/A | 442 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,861 | 0 | 3,439 | 3,884 | 8,858 |
| TOTAL | $2,861 | $52 | $22,450 | $3,884 | $8,858 |
| Total Liabilities | $27,252 | $29,942 | $27,777 | $9,126 | $12,806 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,274 | 4,128 | 4,119 | 4,115 | 4,111 |
| Common Shares | 2 | 1 | 2 | 2 | 2 |
| Retained earnings | -134,343 | -21,549 | -118,730 | -111,818 | -107,263 |
| Other shareholders' equity | -158 | -1,634 | -238 | -218 | -121 |
| TOTAL | $28,272 | $8,536 | $42,416 | $47,941 | $51,546 |
| Total Liabilities And Equity | $55,524 | $38,478 | $70,193 | $57,067 | $64,352 |